Glaxosmithkline Pharmaceuticals informs about analyst meet

15 Feb 2025 Evaluate
Pursuant to Regulation 30 read with Part A of Schedule Ill of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that the recording is uploaded at Audio file – https://india-pharma.gsk.com/media/7833/analysts-meet-audio-recording-14th-feb-2025.mp3 Video file – https://india-pharma.gsk.com/media/7834/analysts-meet-video-recording-14th-feb-2025.mp4.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2857.90 81.30 (2.93%)
03-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.10
Dr. Reddys Lab 1151.25
Cipla 1495.15
Lupin 2094.50
Zydus Lifesciences 901.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...